Suppression of the human immunodeficiency virus long terminal repeat by CD8(+) T cells is dependent on the NFAT-1 element

被引:31
作者
Copeland, KFT [1 ]
McKay, PJ [1 ]
Rosenthal, KL [1 ]
机构
[1] MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,MOLEC VIROL & IMMUNOL PROGRAMME,HAMILTON,ON L8N 3Z5,CANADA
关键词
D O I
10.1089/aid.1996.12.143
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T lymphocytes of HIV-1 infected individuals produce a soluble factor that efficiently suppresses HIV-1 replication at the transcriptional level, We show here that the response of the HIV-1 long terminal repeat (LTR) to mitogenic or Tat-mediated activation is sensitive to the suppressive action of a Herpesvirus saimiri (HVS)-transformed CD8(+) T cell clone from an HIV-infected individual and supernatants from CD8(+) T cells of HIV-1-infected asymptomatic subjects (CD4(+) > 350/mu l). Mutagenesis of NF kappa B or Sp-l elements within the LTR resulted in no change in the ability of CD8(+) T cell supernatants to inhibit Tat- or mitogen-mediated LTR transcription, However, the response to HIV-1 Tat by a LTR in which the interleukin (IL)-2 homology NFAT-1 region was mutated resulted in almost complete elimination of suppression by CD8(+) T cells, This was not observed when the NFAT-1 mutant LTR was activated by mitogen, We have previously shown that gene expression directed by the HIV-1 NF kappa B elements is inhibited by CD8(+) cell-derived supernatants (Copeland ct al., AIDS Res Hum Retroviruses, 1995;11:1321-1326). Taken together, these observations suggest that mitogenic activation, mediated primarily through the NF kappa B enhancer, is susceptible to CDS-mediated inhibition, however, inhibition of Tat-mediated activation may rely upon a different pathway that is NFAT-1 dependent.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 33 条
[1]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[2]   FUNCTIONAL ROLES FOR THE TATA PROMOTER AND ENHANCERS IN BASAL AND TAT-INDUCED EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT [J].
BERKHOUT, B ;
JEANG, KT .
JOURNAL OF VIROLOGY, 1992, 66 (01) :139-149
[3]   TAR-INDEPENDENT ACTIVATION OF THE HIV-1-LTR - EVIDENCE THAT TAT REQUIRES SPECIFIC REGIONS OF THE PROMOTER [J].
BERKHOUT, B ;
GATIGNOL, A ;
RABSON, AB ;
JEANG, KT .
CELL, 1990, 62 (04) :757-767
[4]   EFFICIENT TRANSACTIVATION BY THE HIV-2 TAT PROTEIN REQUIRES A DUPLICATED TAR RNA STRUCTURE [J].
BERKHOUT, B ;
GATIGNOL, A ;
SILVER, J ;
JEANG, KT .
NUCLEIC ACIDS RESEARCH, 1990, 18 (07) :1839-1846
[5]   STABLE GROWTH TRANSFORMATION OF HUMAN LYMPHOCYTES-T BY HERPESVIRUS SAIMIRI [J].
BIESINGER, B ;
MULLERFLECKENSTEIN, I ;
SIMMER, B ;
LANG, G ;
WITTMANN, S ;
PLATZER, E ;
DESROSIERS, RC ;
FLECKENSTEIN, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3116-3119
[6]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[7]  
BRINCHMANN JE, 1991, J ACQ IMMUN DEF SYND, V4, P480
[8]   SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY CD8+ CELLS FROM INFECTED AND UNINFECTED CHIMPANZEES [J].
CASTRO, BA ;
WALKER, CM ;
EICHBERG, JW ;
LEVY, JA .
CELLULAR IMMUNOLOGY, 1991, 132 (01) :246-255
[9]   CD8(+) T-LYMPHOCYTE-MEDIATED INHIBITION OF HIV-1 LONG TERMINAL REPEAT TRANSCRIPTION - A NOVEL ANTIVIRAL MECHANISM [J].
CHEN, CH ;
WEINHOLD, KJ ;
BARTLETT, JA ;
BOLOGNESI, DP ;
GREENBERG, ML .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) :1079-1086
[10]   SUPPRESSION OF ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT BY CD8(+) T-CELLS IS NOT LENTIVIRUS SPECIFIC [J].
COPELAND, KFT ;
MCKAY, PJ ;
ROSENTHAL, KL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (11) :1321-1326